美国 · SEC FORM 4
Natera, Inc.
NTRA · Nasdaq · CIK 0001604821 · Healthcare · Diagnostics & Research
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
315 同一窗口内观察到的 Form 4 交易行
282 sales · 33 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号?
评分构成
活跃窗口内没有合资格买入,因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数?
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示,不会形成负分。
卖出和其他 Form 4 活动会单独显示,不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
Showing the six most active owners; 6 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后,这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2022-05-12 · Rabinowitz Matthew.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。
- 空头股数
- 6,355,450
- 上期报告
- 4,797,175
- 日均成交量
- 1,983,053
- 回补天数
- 3.2
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
Form 4 申报证据
602 transaction lines in the latest 365-day window; 2,649 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-15 | Rabinowitz Matthew | 卖出 (S) | Common Stock | 49,400 | USD 402.70 | USD 19,893,174 | SEC 申报 ↗ |
| 2026-10-15 | Rabinowitz Matthew | 卖出 (S) | Common Stock | 600 | USD 398.09 | USD 238,854 | SEC 申报 ↗ |
| 2026-10-15 | Rabinowitz Matthew | 期权行权/转换 (M) | Common Stock | 50,000 | USD 10.41 | USD 520,500 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-15 | Rabinowitz Matthew | 卖出 (S) | Common Stock | 49,400 | USD 402.70 | USD 19,893,174 | SEC 申报 ↗ |
| 2026-10-15 | Rabinowitz Matthew | 卖出 (S) | Common Stock | 600 | USD 398.09 | USD 238,854 | SEC 申报 ↗ |
| 2026-10-15 | Rabinowitz Matthew | 期权行权/转换 (M) | Common Stock | 50,000 | USD 10.41 | USD 520,500 | SEC 申报 ↗ |
| 2026-10-07 | Rabinowitz Matthew | 赠与 (G) | Common Stock | 6,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-10-01 | Moshkevich Solomon | 卖出 (S) | Common Stock | 3,000 | USD 414.22 | USD 1,242,645 | SEC 申报 ↗ |
| 2026-10-01 | Chapman Steven Leonard | 卖出 (S) | Common Stock | 1,273 | USD 413.31 | USD 526,144 | SEC 申报 ↗ |
| 2026-09-23 | Sheena Jonathan | 卖出 (S) | Common Stock | 18,064 | USD 388.01 | USD 7,008,974 | SEC 申报 ↗ |
| 2026-09-16 | Moshkevich Solomon | 赠与 (G) | Common Stock | 945 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-16 | Sheena Jonathan | 卖出 (S) | Common Stock | 3,150 | USD 354.20 | USD 1,115,716 | SEC 申报 ↗ |
| 2026-09-15 | Sheena Jonathan | 卖出 (S) | Common Stock | 6,000 | USD 350.07 | USD 2,100,420 | SEC 申报 ↗ |
| 2026-09-15 | Rabinowitz Matthew | 卖出 (S) | Common Stock | 52,000 | USD 347.30 | USD 18,059,409 | SEC 申报 ↗ |
| 2026-09-14 | Rabinowitz Matthew | 卖出 (S) | Common Stock | 50,000 | USD 334.76 | USD 16,738,080 | SEC 申报 ↗ |
| 2026-09-11 | Rabinowitz Matthew | 卖出 (S) | Common Stock | 50,000 | USD 327.96 | USD 16,398,181 | SEC 申报 ↗ |
| 2026-09-02 | Moshkevich Solomon | 卖出 (S) | Common Stock | 15,160 | USD 326.89 | USD 4,955,652 | SEC 申报 ↗ |
| 2026-09-01 | Moshkevich Solomon | 卖出 (S) | Common Stock | 3,000 | USD 320.73 | USD 962,194 | SEC 申报 ↗ |
| 2026-09-01 | Chapman Steven Leonard | 卖出 (S) | Common Stock | 1,698 | USD 320.99 | USD 545,041 | SEC 申报 ↗ |
| 2026-08-10 | Fesko John | 卖出 (S) | Common Stock | 6,517 | USD 321.53 | USD 2,095,411 | SEC 申报 ↗ |
| 2026-08-10 | Sheena Jonathan | 卖出 (S) | Common Stock | 6,000 | USD 325.32 | USD 1,951,920 | SEC 申报 ↗ |
| 2026-08-07 | Sheena Jonathan | 卖出 (S) | Common Stock | 9,150 | USD 315.66 | USD 2,888,322 | SEC 申报 ↗ |
| 2026-08-07 | Rabinowitz Matthew | 卖出 (S) | Common Stock | 2,000 | USD 320.90 | USD 641,800 | SEC 申报 ↗ |
| 2026-08-06 | Fesko John | 奖励/授予 (A) | Common Stock | 20,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-04 | Brophy Michael Burkes | 卖出 (S) | Common Stock | 478 | USD 274.22 | USD 131,077 | SEC 申报 ↗ |
| 2026-08-03 | Sheena Jonathan | 卖出 (S) | Common Stock | 109 | USD 267.99 | USD 29,211 | SEC 申报 ↗ |
| 2026-08-03 | Rabinowitz Matthew | 卖出 (S) | Common Stock | 731 | USD 267.99 | USD 195,901 | SEC 申报 ↗ |
| 2026-08-03 | RABINOWITZ DANIEL | 卖出 (S) | Common Stock | 334 | USD 267.99 | USD 89,509 | SEC 申报 ↗ |
| 2026-08-03 | Moshkevich Solomon | 卖出 (S) | Common Stock | 3,410 | USD 265.58 | USD 905,632 | SEC 申报 ↗ |
| 2026-08-03 | Fesko John | 卖出 (S) | Common Stock | 295 | USD 267.99 | USD 79,057 | SEC 申报 ↗ |
| 2026-08-03 | Chapman Steven Leonard | 卖出 (S) | Common Stock | 3,076 | USD 266.39 | USD 819,430 | SEC 申报 ↗ |
| 2026-08-03 | Brophy Michael Burkes | 卖出 (S) | Common Stock | 317 | USD 267.99 | USD 84,953 | SEC 申报 ↗ |
| 2026-07-29 | Brophy Michael Burkes | 卖出 (S) | Common Stock | 1,863 | USD 249.38 | USD 464,595 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | NTRA |
| CIK | 0001604821 |
| 行业 | Healthcare |
| 细分行业 | Diagnostics & Research Yahoo Finance |
| SEC SIC | 8071 Services-Medical Laboratories |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 2,649 transaction lines from 2020-01-02 to 2026-10-15 7 P purchase lines · 1,657 S sale lines · 985 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.